A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

NCT05546151 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: BMS-986322
OTHER: Placebo for BMS-986322

Sponsor

Bristol-Myers Squibb